A Study to Investigate Safety of Belumosudil in Participants Aged 12 Years and Above, With Chronic Graft-versus-host Disease (cGVHD)

NCT07135973 · clinicaltrials.gov ↗
PHASE4
Phase
NOT_YET_RECRUITING
Status
26
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sanofi